Effect of Probenecid on Pharmacokinetics and Tolerability of Olmesartan in Healthy Chinese Volunteers

• Päätekijät: Kun-Yan Li, PhD (Tekijä), Yu Qiu, MS (Tekijä), Yun Jiang, BS (Tekijä), Chen-Hui Luo, MS (Tekijä), Xiao-Ping Lin, BS (Tekijä), Jing Wang, BS (Tekijä), Nong Yang, MS (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: Elsevier, 2014-12-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background: Olmesartan is an angiotensin II receptor antagonist and is effective and well tolerated in the treatment of arterial hypertension. Probenecid is a well-established hypouricemic agent for the treatment of hyperuricemia and gout. Objective: The goal of this study was to examine the impact...